Schanda, Jakob E.
Obermayer-Pietsch, Barbara
Sommer, Gerhard
Heuberer, Philipp R.
Laky, Brenda
Muschitz, Christian
Pastl, Klaus
Pastl, Eva
Fialka, Christian
Mittermayr, Rainer
Grillari, Johannes
Foessl, Ines
Article History
Received: 12 September 2021
Accepted: 25 April 2022
First Online: 5 May 2022
Declarations
:
: Tissue grafts in Germany are regulated as medicinal products under the German Medicinal Products Act (Arzneimittelgesetz, AMG). All tissues are acquired from non-profit tissue donation organizations after informed consent and according to the AMG and to the Transplantation Act (Transplantationsgesetz, TPG) regulations. All specimens used in this study were provided by the tissue bank of the German Institute for Cell- and Tissue-Replacement (Deutsches Institut für Zell- und Gewebeersatz – DIZG, Berlin, Germany).
: Not applicable.
: KP is Chief Executive Officer and Medical Director of surgebright. EP is Vice Medical Director of surgebright. JES, BOP, GS, PRH, BL, CM, CF, RM, JG, IF certify that he or she have no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.